Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells. It can occur in extranodal sites and solid organs, leading to significant clinical implications. Accurate coding with ICD-10 Code C83.39 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
What is ICD-10 Code C83.39 for Diffuse large B-cell lymphoma, extrnod and solid organ sites?
ICD-10 Code C83.39 represents Diffuse large B-cell lymphoma occurring in extranodal and solid organ sites. This code is used when documenting cases of DLBCL that do not fit into other specified categories. It is crucial for accurate clinical documentation and billing, particularly in oncology settings, to ensure appropriate treatment and resource allocation.
ICD-10 Code C83.39 – Clinical Definition and Explanation of Diffuse large B-cell lymphoma, extrnod and solid organ sites
Diffuse large B-cell lymphoma is an aggressive form of lymphoma that arises from B-lymphocytes. It can manifest in various extranodal sites, including the gastrointestinal tract, skin, and central nervous system. The condition requires prompt medical attention due to its rapid progression and potential for systemic involvement.
Key Clinical Features:
- Rapidly enlarging lymph nodes or masses in extranodal sites.
- B symptoms such as fever, night sweats, and weight loss.
- Cytopenias due to bone marrow involvement.
- Elevated lactate dehydrogenase (LDH) levels indicating tumor burden.
ICD-10 Code C83.39 for Diffuse large B-cell lymphoma, extrnod and solid organ sites – SOAP Notes & Clinical Use
ICD-10 Code C83.39 is utilized in SOAP notes to document the presence of Diffuse large B-cell lymphoma in clinical workflows. It aids in capturing symptoms, assessments, and treatment plans, ensuring comprehensive patient care in both acute and chronic settings.
What Does ICD-10 Code C83.39 for Diffuse large B-cell lymphoma, extrnod and solid organ sites Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C83.39 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Diffuse large B-cell lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C83.39 – Diffuse large B-cell lymphoma, extrnod and solid organ sites
The management of Diffuse large B-cell lymphoma often necessitates hospitalization due to its aggressive nature. Treatment typically involves chemotherapy and may require supportive care.
Antibiotic Therapy:
- Not applicable as DLBCL is not an infectious condition.
Supportive Care:
- Management of symptoms such as pain and nausea.
- Blood transfusions for anemia or thrombocytopenia.
- Nutritional support to maintain strength and weight.
Infection Control:
- Standard precautions to prevent infections in immunocompromised patients.
- Monitoring for signs of infection during chemotherapy.
How to Document Symptoms of Diffuse large B-cell lymphoma, extrnod and solid organ sites (ICD-10 C83.39) in SOAP Notes
Subjective:
- Patient reports unexplained weight loss of 15 pounds over the last month.
- Complaints of night sweats and persistent fatigue.
- Notable increase in lymph node size in the neck and abdomen.
Objective:
- Physical examination reveals enlarged cervical and axillary lymph nodes.
- Laboratory tests show elevated LDH levels.
- Imaging studies indicate masses in the spleen and liver.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Diffuse large B-cell lymphoma, extrnod and solid organ sites (ICD-10 Code C83.39)
Assessment:
- Diagnosis: Diffuse large B-cell lymphoma, extranodal and solid organ involvement, high grade.
- ICD-10 Code: C83.39.
- Contributing factors: Advanced age and immunocompromised status.
Plan:
- Initiate chemotherapy regimen (e.g., R-CHOP).
- Educate patient on potential side effects and symptom management.
- Schedule follow-up appointments for monitoring treatment response.
Treatment & Plan Section for ICD-10 Code C83.39 – Diffuse large B-cell lymphoma, extrnod and solid organ sites
- First-line pharmacologic treatment includes R-CHOP chemotherapy.
- Non-pharmacologic strategies involve nutritional support and psychosocial counseling.
- Monitoring includes regular imaging and laboratory tests to assess treatment efficacy.
- Follow-up practices should include scheduled visits to evaluate for recurrence.
Using ICD-10 Code C83.39 for Diffuse large B-cell lymphoma, extrnod and solid organ sites in Billing & SOAP Note Compliance
- Select accurate subcodes based on clinical severity or complications.
- Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
- Ensure treatment plans align with clinical guidelines to support justified billing.
- Only list CPT codes that are commonly billed with ICD-10 Code C83.39 based on standard medical coding practices.
Related ICD-10 Codes Often Used with Diffuse large B-cell lymphoma, extrnod and solid organ sites
- C83.10 – Diffuse large B-cell lymphoma, unspecified site
- C83.19 – Diffuse large B-cell lymphoma, other site
ICD-10 Code C83.39 in Medical Billing and Insurance for Diffuse large B-cell lymphoma, extrnod and solid organ sites
ICD-10 Code C83.39 is critical in medical billing, particularly in hospital and oncology settings, to ensure accurate claims processing.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
- Use this code in inpatient and outpatient settings for consistent billing.
- Ensure that all chart elements, including patient history and treatment response, are complete.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
| 77014 | Radiologic guidance for needle placement. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.39 for Diffuse large B-cell lymphoma, extrnod and solid organ sites
What are the common symptoms of Diffuse large B-cell lymphoma?
Common symptoms include swollen lymph nodes, unexplained weight loss, fever, night sweats, and fatigue. Patients may also experience abdominal pain if the lymphoma affects the gastrointestinal tract.
How is Diffuse large B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes or tissues to confirm the presence of large B-cells.
What treatment options are available for Diffuse large B-cell lymphoma?
Treatment usually includes chemotherapy regimens such as R-CHOP, radiation therapy, and in some cases, stem cell transplantation, depending on the stage and patient's overall health.
Is Diffuse large B-cell lymphoma curable?
Many patients with Diffuse large B-cell lymphoma can achieve remission with appropriate treatment. However, outcomes vary based on factors such as age, stage at diagnosis, and response to therapy.
